Treatment of Chlamydia trachomatis infections of the female lower genital tract. 1982

H Gjønnaess

Chlamydia trachomatis infections of the female lower genital tract may cause cervicitis, a condition which, even when asymptomatic, as it often is, can have serious consequences in both the short and the long term. Treatment, therefore, should be instituted as soon as such infections are diagnosed. Tetracyclines are the therapy of choice, with erythromycin and trimethoprim/sulfamethoxazole as therapeutic alternatives. The duration of treatment should be for not less than 8 to 10 days. Concomitant infections with C. trachomatis and Neisseria gonorrhoeae require special therapeutic considerations. As with any other sexually transmitted infection, management of chlamydial infections demands simultaneous partner treatment. Screening by culture is proposed for high-risk groups, such as women applying for legal abortion and those undergoing implantation of an intrauterine contraceptive device.

UI MeSH Term Description Entries
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D002575 Uterine Cervicitis Inflammation of the UTERINE CERVIX. Cervicitis,Cervicitides,Cervicitides, Uterine,Cervicitis, Uterine,Uterine Cervicitides
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006069 Gonorrhea Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. Neisseria gonorrhoeae Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

H Gjønnaess
January 1999, Infectious diseases in obstetrics and gynecology,
H Gjønnaess
January 1984, Acta oto-laryngologica. Supplementum,
H Gjønnaess
July 1992, The Journal of infection,
H Gjønnaess
December 2002, Best practice & research. Clinical obstetrics & gynaecology,
H Gjønnaess
January 1995, Infectious diseases in obstetrics and gynecology,
H Gjønnaess
January 1996, Indian journal of dermatology, venereology and leprology,
H Gjønnaess
September 2017, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!